文献速递安宁疗护老年综合评估

新冠疫情期间预先护理计划中的种族差异变化

Disparities in Advance Care Planning: Did COVID-19 Change Anything?
PubMed 文献 · J Am Geriatr Soc · 2026-05-13

该横断面调查纳入10家初级保健诊所中≥65岁重病成人428例(55.9%黑人,44.2%白人,平均年龄74.6岁),于2021年2月至2022年9月评估新冠相关ACP讨论与治疗偏好。结果显示新冠相关ACP讨论无种族差异,但黑人参与者更偏好延长生命治疗,且偏好延长生命治疗者更可能进行新冠相关ACP讨论。

要点

  • 新冠相关ACP讨论无种族差异,与疫情前研究不同。
  • 黑人参与者更常偏好延长生命治疗(28.5% vs 10.3%)。
  • 偏好延长生命治疗预测更多新冠相关ACP讨论(OR 1.98)。

核心结论

  • 与疫情前ACP研究不同,新冠相关ACP讨论未观察到种族差异,但治疗偏好差异持续存在。

研究设计与样本

  • 2021年2月至2022年9月在10家参与临床试验的初级保健诊所开展横断面调查,纳入≥65岁重病成人428例。

主要发现

  • 25%参与者报告与家人/朋友讨论新冠治疗偏好,6%报告与医生讨论。
  • 黑人参与者较白人更常因疫情增加参与ACP意愿(22.4% vs 14.0%,p=0.016)。
  • 新冠相关ACP讨论无种族差异(家人/朋友:22.7% vs 28.3%,p=0.19;医生:6.9% vs 4.8%,p=0.37)。
  • 多数参与者偏好限时尝试延长生命治疗(白人71%,黑人56.2%),偏好因种族而异(p<0.0001)。
  • 校正模型中种族与新冠相关ACP讨论无关(OR 0.72,95%CI 0.44-1.18),偏好延长生命治疗预测更多讨论(OR 1.98,95%CI 1.14-3.44)。

临床怎么用

  • 对重病老年人应提供文化敏感、情境化的ACP方法,关注治疗偏好差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rates of advance care planning (ACP) are lower and preferences for life-prolonging treatment are higher among Black compared to White older adults. We examined whether these differences persisted during the COVID-19 pandemic. METHODS: Between February 2021 and September 2022, we conducted a cross-sectional COVID-19-focused survey of seriously ill adults ≥ 65 years in 10 primary care clinics participating in a clinical trial of two ACP interventions. Logistic regression models examined associations between COVID-19 related ACP discussion (defined as discussions with family, friends, or doctors about COVID-related medical care) and treatment preferences if very sick with COVID-19 (life-prolonging treatment, comfort care, trial of life-prolonging with transition to comfort care if no improvement) overall and by race, controlling for baseline characteristics. RESULTS: Among 428 participants (55.9% Black, 44.2% White; mean age 74.6), 25% reported discussing COVID-19 treatment preferences with family/friends and 6% with doctors. Most reported no change in willingness to participate in ACP due to the pandemic, though increased willingness was more common among Black than White participants (22.4% vs. 14.0%, p = 0.016). Despite this, COVID-19-related ACP discussion did not differ by race (family/friends: 22.7% vs. 28.3%, p = 0.19; doctors: 6.9% vs. 4.8%, p = 0.37). Most seriously ill older adults preferred a time-limited trial of life-prolonging treatment (71% White, 56.2% Black); though preferences varied by race (p < 0.0001); Black participants compared to White participants more often preferred life-prolonging treatment (28.5% vs. 10.3%). In adjusted models, race was not associated with COVID-19-related ACP discussion (OR 0.72, 95% CI 0.44-1.18), while preferences for life-prolonging treatments predicted greater COVID-19 related ACP discussion (OR 1.98, 95% CI 1.14-3.44). CONCLUSION: In contrast to pre-pandemic ACP research, no racial differences were observed in COVID-19-related ACP discussion, though differences in treatment preferences persisted. These findings underscore the need for culturally responsive, context-sensitive ACP approaches among seriously ill older adults.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Gangavati A, Johnson KS, Platt A, et al. Disparities in Advance Care Planning: Did COVID-19 Change Anything? J Am Geriatr Soc. 2026. PMID: 42124477. doi:10.1111/jgs.70509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。